Cited by 506Fatty Acid Research and HealthGut microbiota and healthProbiotics and Fermented Foods

A randomised trial of the effect of omega-3 polyunsaturated fatty acid supplements on the human intestinal microbiota

Watson, Henry, Mitra, Suparna, Croden, Fiona C, Taylor, Morag, Wood, Henry M, Perry, Sarah L, Spencer, Jade A, Quirke, Phil +5 more·2018·Gut

Abstract

Objective Omega-3 polyunsaturated fatty acids (PUFAs) have anticolorectal cancer (CRC) activity. The intestinal microbiota has been implicated in colorectal carcinogenesis. Dietary omega-3 PUFAs alter the mouse intestinal microbiome compatible with antineoplastic activity. Therefore, we investigated the effect of omega-3 PUFA supplements on the faecal microbiome in middle-aged, healthy volunteers (n=22). Design A randomised, open-label, cross-over trial of 8 weeks’ treatment with 4 g mixed eicosapentaenoic acid/docosahexaenoic acid in two formulations (soft-gel capsules and Smartfish drinks), separated by a 12-week ‘washout’ period. Faecal samples were collected at five time-points for microbiome analysis by 16S ribosomal RNA PCR and Illumina MiSeq sequencing. Red blood cell (RBC) fatty acid analysis was performed by liquid chromatography tandem mass spectrometry. Results Both omega-3 PUFA formulations induced similar changes in RBC fatty acid content, except that drinks were associated with a larger, and more prolonged, decrease in omega-6 PUFA arachidonic acid than the capsule intervention (p=0.02). There were no significant changes in α or β diversity, or phyla composition, associated with omega-3 PUFA supplementation. However, a reversible increased abundance of several genera, including Bifidobacterium , Roseburia and Lactobacillus was observed with one or both omega-3 PUFA interventions. Microbiome changes did not correlate with RBC omega-3 PUFA incorporation or development of omega-3 PUFA-induced diarrhoea. There were no treatment order effects. Conclusion Omega-3 PUFA supplementation induces a reversible increase in several short-chain fatty acid-producing bacteria, independently of the method of administration. There is no simple relationship between the intestinal microbiome and systemic omega-3 PUFA exposure. Trial registration number ISRCTN18662143.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/gutjnl-2017-314968

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • ω-3 fatty acids have been proposed to restore the eubiotic state in pathological conditions by increasing beneficial bifidobacteria and decreasing enterobacteria, which in turn supports an anti-inflammatory environment through the production of SCFAs and suppression of endotoxemia.

    “Indeed, ω-3 fatty acids have been proposed to restore the eubiotic state in pathological conditions by increasing the beneficial bifidobacteria and decreasing enterobacteria, which in turn supports an anti-inflammatory environment through the production of SCFAs and suppression of endotoxemia (81,141).”
  • In humans, healthier polyunsaturated fatty acids (e.g., omega-3 PUFAs) promote the growth of beneficial bacteria, including butyrate producers such as Lactobacillus, Lachnospira, Roseburia, and Bifidobacterium, and are correlated with higher microbial diversity as well as taxa from the families Lachnospiraceae and Ruminococcaceae.

    “In humans, healthier polyunsaturated fatty acids (e.g., omega-3 PUFAs) promote the growth of beneficial bacteria, including butyrate producers such as Lactobacillus, Lachnospira, Roseburia, and Bifidobacterium (81), and are correlated with higher microbial diversity as well as taxa from the families Lachnospiraceae and Ruminococcaceae (82).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [33]33. Peters BA, Dominianni C, Shapiro JA, Church TR, Wu J, Miller G, Yuen E, Freiman H, Lustbader I, Salik J, Friedlander C, Hayes RB, Ahn J. The gut microbiota in conventional and serrated precursors of colorectal cancer. Microbiome 2016; 4 :69.

Cited by

Sorted by citations

Authors
Watson, H., Mitra, S., Croden, F. C., Taylor, M., Wood, H. M., Perry, S. L., Spencer, J. A., Quirke, P., Toogood, G. J., Lawton, C. L., Dye, L., Loadman, P. M., & Hull, M. A.
Affiliations
  • University of Leeds (GB)
  • Leeds General Infirmary (GB)
  • University of Bradford (GB)
  • Institute of Cancer and Pathology, St James’s University Hospital, University of Leeds, Leeds, UK
  • St James's University Hospital (GB)
Corresponding author
Hull, Mark A
Venue
Gut
Publisher
BMJ
Published
2017-09-26
Volume
67
Issue
11
Pages
1974-1983
ISSN
  • 0017-5749 (ISSN-L)
  • 1468-3288
OpenAlex
W2758490346
Cited by
506
References
39
Citations by year
2026: 42 · 2025: 57 · 2024: 59 · 2023: 71 · 2022: 79 · 2021: 75 · 2020: 64 · 2019: 38 · 2018: 16 · 2017: 4
FWCI
27.58
Type
journal article
Language
en
Open access
closed
Locations
  • Gut (publishedVersion)
  • PubMed (publishedVersion)
  • White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
  • Bradford Scholars (University of Bradford) (acceptedVersion)
  • HighWire Press Open Archive (submittedVersion)
Funders
Medical Research Council (MC_G1002465)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
Keywords
omega-3 polyunsaturated fatty acids, eicosapentaenoic acid, docosahexaenoic acid, dietary supplementation, gut microbiota, fecal microbiota, short-chain fatty acid-producing bacteria, Bifidobacterium, Roseburia, Lactobacillus, red blood cell fatty acids, arachidonic acid, colorectal cancer prevention, administration methods, soft gel capsules
MeSH terms
Gastrointestinal Microbiome, Aged, Chromatography, Liquid, Fatty Acids, Feces, Female, Humans, Male, Middle Aged, Mass Spectrometry, Fatty Acids, Omega-3, Polymerase Chain Reaction, Cross-Over Studies, Dietary Supplements, Healthy Volunteers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review